Researchers have conducted extensive studies to alleviate the burden of HIV/AIDS medication users who have long complained about the fatigue associated with long-term pill consumption. Scientists have developed a monthly injectable antiretroviral drug (ARV) as a solution. The current injection combines cabotegravir and rilpivirine.
What is the quality of this drug?
Two studies were conducted, one involving long-term HIV patients who were switched from oral medication to the injectable, and another with newly diagnosed HIV patients who started this injection. Both studies showed positive results in suppressing the HIV virus.
What are its side effects?
So far, no specific side effects have been announced regarding this drug, except for the usual pain during the injection, which is common for all types of injections.
Is this drug available in Tanzania?
As of now, this drug has not been introduced in Tanzania. However, it has been approved and is in use in Canada, the United States, and all European countries. Currently, there is no information on when the drug will be available in Tanzania.
How is it used?
As mentioned earlier, patients only need to receive one injection per month instead of taking daily pills. Additionally, individuals who want to protect themselves from HIV can take the injection a month before engaging in risky activities without the fear of transmission.
STAY ALIVE.
